Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons

Annals of Oncology

Volumn 11, Issue SUPPL. 1, 2000, Pages

  Hutchison, R E ^a,i   Finch, C ^a,i   Kepner, J ^b,i   Fuller, C ^a,i   Bowman, P ^c,i   Link, M ^d,i   Schwenn, M ^e,i   Laver, J ^f,i   Desai, S ^g,i   Barrett, D ^a,i   Murphy, S B ^h,i  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c Cook Children's Medical Center ^*  (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g CROSS CANCER INSTITUTE   (Canada)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ Pediatric Oncology Group   (United States)

Author keywords

BCL 2; BCL 6; Burkitt lymphoma; Burkitt like lymphoma; Large B cell lymphoma; Non Hodgkin's lymphoma

Indexed keywords

B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 17544402364     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/11.suppl_1.S35     Document Type: Conference Paper

References (20)

1. Harris NL, Jaffe ES, Stein H et al. A Revised European American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
2. Hutchison RE, Murphy SB, Fairclough DL et al. Diffuse small non-cleaved cell lymphoma in children, Burkitts versus non-Burkitt's types. Results from the Pediatric Oncology Group and St. Jude Children's Research Hospital. Cancer 1989; 64: 23-8.
3. Wilson JF, Kjeldsberg CR. Sposto R et al. The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducihilily and relevance of the histologic classification of 'undifferentiated' lymphomas (Burkitt's versus non-Burkitt's). Hum Pathol 1987: 18: 1008-14.
4. Yano T, van Krieken JH, Magrath IT et al. Histogenetic correlations between subcategories of small non-cleaved cell lymphomas. Blood 1992; 79: 1282-90.
5. Writing Committee. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112-35.
6. Freilone R, Halton JH. Note on an exact treatment of contingency, goodness of fit and other problems of significance. J Am Stat Assoc 1951; 31: 675-701.
7. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958; 46: 218-23.
8. Wright DH. What is Burkitts lymphoma? J Pathol 1997; 182: 125-7.
9. Berard CW, O'Conor GT, Thomas LB, Torloni H. Histopathological definition of Burkitts tumour. Bull WHO 1969; 40: 601-7.
10. Rappaport H. Tumors of the Hematopoietic System. Washington, DC: Armed Forces Institute of Pathology 1966.
11. Lukes RJ, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer 1974: 34 (Suppl): 503.
12. Lennert K, Mohri N, Stein H, Kaiserling E. The histopathology of malignant lymphoma. Br J Haematol 1975; 31 (Suppl): 193-203.
13. Jaffe ES, Berard CW, Harris NL et al. Proposed World Health Organization Classification of neoplastic diseases of hematopoietic and lymphoid tissues. Am J Surg Pathol 1997; 21: 114-21.
14. Evan GI, Lewis GK, Ramsay G, Bishop JM. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 1985; 5: 3610-6.
15. Weiss LM, Warnke RA, Sklar J, Cleary ML. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987; 317: 1185-9.
16. Falini B, Fizzotti M, Pileri S et al. BCL-6 protein expression in normal and neoplastic lymphoid tissues. Ann Oncol 1997; 8 (Suppl 2): 101-4.
17. Dalla-Favera R, Ye BH, Caltoretti G et al. BCL-6 in diffuse largecell lymphomas. Important Advances Oncol 1996; 139-48.
18. Capello D, Carbone A, Pastore C et al. Point mutations of the BCL-6 gene in Burkitt's lymphoma. Br J Haematol 1997; 99: 168-70.
19. Spina D, Leoncini L, Megha T et al. Stage-related differences of mitotic and apoptotic indices, and BCL-2 protein expression in diffusely growing non-Hodgkin's lymphomas. Int J Cancer 1996; 68: 436-40.
20. Lai R, Arber DA, Chang KL et al. Frequency of BCL-2 expression in non-Hodgkin's lymphoma: A study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 1998; 11: 864-9.